ASSAY FOR ANALYSES OF RABIES VIRUS GLYCOPROTEIN
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 1, 2015
app pub date -
Oct 15, 2013
filing date -
Oct 12, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Provided are processes of determining die immimogenicity of a rabies virus vaccine preparation that for the first tiine correlates well with in vivo results. The methods capitalize on an ECL assay for RABV G protein that is sensitive, reproducible, and can be used to quickly assess characteristics of new vaccine preparations.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully